Neogen (NEOG) Total Non-Current Liabilities (2011 - 2026)
Neogen (NEOG) posted quarterly Total Non-Current Liabilities of $1.2 billion for Q2 2026, down 9.04% year-over-year from $1.3 billion in Q2 2025, and little changed quarter-over-quarter from $1.2 billion in Q1 2026.
Neogen (NEOG) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Neogen's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $1.2 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 9.04% year-over-year to $1.2 billion; the TTM figure through May 2026 stood at $1.2 billion (down 9.04% YoY), while the FY2026 annual figure was $1.2 billion, down 9.04% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $1.4 billion in Q4 2022, with the low at $83.0 million in Q3 2022.
- The 5-year median for Total Non-Current Liabilities is $1.3 billion (2025), against an average of $1.1 billion.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities surged 1630.7% in 2022, then fell 9.64% in 2025.
- Neogen's Total Non-Current Liabilities stood at $1.4 billion in 2022, then dropped by 1.54% to $1.4 billion in 2023, then dropped by 5.29% to $1.3 billion in 2024, then declined by 9.64% to $1.2 billion in 2025, then slipped by 0.36% to $1.2 billion in 2026.
- Business Quant data shows NEOG's Total Non-Current Liabilities at $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 1.21 Bn |
| Feb 28, 2026 | 1.21 Bn |
| Nov 30, 2025 | 1.21 Bn |
| Aug 31, 2025 | 1.22 Bn |
| May 31, 2025 | 1.33 Bn |
| Feb 28, 2025 | 1.33 Bn |
| Nov 30, 2024 | 1.34 Bn |
| Aug 31, 2024 | 1.33 Bn |
| May 31, 2024 | 1.37 Bn |
| Feb 29, 2024 | 1.40 Bn |
| Nov 30, 2023 | 1.42 Bn |
| Aug 31, 2023 | 1.38 Bn |
| May 31, 2023 | 1.38 Bn |
| Feb 28, 2023 | 1.35 Bn |
| Nov 30, 2022 | 1.44 Bn |
| Aug 31, 2022 | 82.95 Mn |
| May 31, 2022 | 94.86 Mn |
| Feb 28, 2022 | 86.91 Mn |
| Nov 30, 2021 | 83.25 Mn |
| Aug 31, 2021 | 72.59 Mn |